The author views Aemetis as a high-risk balance-sheet story where an overlooked India ethanol IPO and a tight share supply could create an asymmetric short-squeeze setup into the shareholder vote.
Unpriced research observations (excluded from Calls and Returns):
AMTX — LONG Author argues Aemetis' overlooked Aemetis India ethanol business could be IPO'd and that even a minority stake sale could raise enough to repay the Series A preferred and reduce parent-level dilution. Because authorized share supply is constrained until the shareholder vote while short interest is high relative to free float, any funding/refinancing/India IPO progress or delay to dilution could force rapid short covering into Feb 20. Main stated risk is the heavily indebted balance sheet, capex needs and little cash, which may cause default or further dilution and extreme price moves either way. resolved_entity_name_mismatch
In a thin float, any positive development around funding, refinancing, or the India IPO, or even delays to dilution, can force rapid repositioning.